Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

0.8149
Delayed Data
As of Sep 30
 +0.0316 / +4.03%
Today’s Change
0.70
Today|||52-Week Range
6.25
-66.19%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Corvus Pharmaceuticals Inc have a median target of 3.75, with a high estimate of 4.00 and a low estimate of 3.50. The median estimate represents a +360.18% increase from the last price of 0.81.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Corvus Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.14
Sales
$0.00
Reporting Date
Nov 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 19.44%
 
 
 
 
 
 
Growthannually 36.41%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.